Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses

Journal of Medical Virology

Volumn 80, Issue 2, 2008, Pages 352-359

  Cello, Jeronimo ^a   Toyoda, Hidemi ^a   DeJesus, Nidia ^a   Dobrikova, Elena Y ^b   Gromeier, Matthias ^b   Wimmer, Eckard ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biosafety; Growth phenotype; Neuroattenuation; Oncolytic; Poliovirus

Indexed keywords

ONCOLYTIC VIRUS; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSAFETY; BRAIN; BRAIN TUMOR; CANCER THERAPY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM TUMOR; CHIMERA; GLIOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLIOMYELITIS VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOVIRUS; SPINAL CORD; TRANSGENIC MOUSE; VIRUS GENOME; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; BRAIN; CELL LINE; GENOME, VIRAL; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; ONCOLYTIC VIROTHERAPY; POLIOVIRUS; RECEPTORS, VIRUS; RECOMBINATION, GENETIC; RHINOVIRUS;

ANIMALIA; MIRIDAE; MUS; MUS MUSCULUS; POLIOVIRUS; RHINOVIRUS;

EID: 37549003697     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21063     Document Type: Article

References (25)

1. American Cancer Society Surveillance Research. 2002. Cancer facts and figures 2002. Atlanta: American Cancer Society, Inc. p 1-44.
2. Campbell SA, Gromeier M. 2005a. Oncolytic viruses for cancer therapy I. Cell-external factors: Virus entry and receptor interaction. Onkologie 23:144-149.
3. Campbell SA, Gromeier M. 2005b. Oncolytic viruses for cancer therapy II. Cell-internal factors for conditional growth in neoplastic cells. Cell-external factors: Virus entry and receptor interaction. Onkologie 204:209-215.
4. Campbell SA, Lin J, Dobrikova EY, Gromeier M. 2005. Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells. J Virol 79:6281-6290.
5. Chumakov K, Dragunsky E, Ivshina A, Enterline J, Wells V, Nomura T, Gromeier M, Wimmer E. 2001. Inactivated vaccines based on alternatives to wild-type seed virus. Dev Biol (Basel) 105:171-177.
6. Ford DJ, Ropka SL, Collins GH, Jubelt B. 2002. The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitis. Micro Path 33:97-107.
7. Gromeier M, Alexander L, Wimmer E. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc Natl Acad Sci USA 93:2370-2375.
8. Gromeier M, Bossert B, Arita M, Nomoto A, Wimmer E. 1999. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol 73:958-964.
9. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E. 2000. Intergeneric poliovirus recombinants for the treatment of malignant gliomas. Proc Natl Acad Sci USA 97:6803-6808.
10. Haller AA, Stewart SR, Semler BL. 1996. Attenuation stem-loop lesions in the 5′ noncoding region of poliovirus RNA: Neuronal cell-specific translations defects. J Virol 70:1467-1474.
11. Iwasaki A, Welker R, Mueller S, Linehan M, Nomoto A, Wimmer E. 2002. Immunoflorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: Implications for poliovirus infection. J Infect Dis 186:585-592.
12. Kohara M, Omata T, Kameda A, Semler BL, Itoh H, Wimmer E, Nomoto A. 1985. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol 53:786-792.
13. La Monica N, Racaniello VR. 1989. Differences in replication of attenuated and neurovirulent poliovirus in human neuroblastoma cell line SH-SY5Y. J Virol 63:2357-2360.
14. Levin VA, Leibel SA, Gutin PH. 1997. Neoplasms of the central nervous system. In: DeVitra VT Jr, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology 5th edition. Philadelphia: Lippincott-Raven. p 2022-2082.
15. Lwoff A. 1959. Factors influencing the evolution of viral disease at the cellular level and in the organism. Bacteriol Rev 23:109-124.
16. Malnou CE, Werner A, Borman A, Westhof E, Kean KM. 2004. Effects of vaccine strain mutations in domain V of the internal ribosome entry segment compared in the wild type poliovirus type 1 context. J Biol Chem 279:10261-10269.
17. Merrill MK, Gromeier M. 2006. The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. J Virol 80:6936-6942.
18. Merrill MK, Bernhardt G, Sampson JH, Wikstrand CJ, Bigner DD, Gromeier M. 2004. Poliovirus receptor CD155-targeted oncolysis of glioma. Neuro-oncol 6:208-217.
19. Merrill MK, Dobrikova EY, Gromeier M. 2006. Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76. J Virol 80:3147-3156.
20. Ochiai H, Moore SA, Archer GE, Okamura T, Chewning TA, Marks JR, Sampson JH, Gromeier M. 2004. Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus. Clin Cancer Res 10:4831-4838.
21. Ochiai H, Campbell SA, Archer GE, Chewning TA, Dragunsky E, Ivanov A, Gromeier M, Sampson JH. 2006. Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus. Clin Cancer Res 12:1349-1354.
22. Paul AV, Mugavero J, Yin S, Hobson S, Schultz S, van Boom JH, Wimmer E. 2000. Studies on the attenuation phenotype of polio vaccines: Poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg. Virology 272:72-84.
23. Pincus SE, Diamond DC, Emini EA, Wimmer E. 1986. Guanidine-selected mutants of poliovirus: Mapping of point mutations to polypeptide 2C. J Virol 57:638-646.
24. Ries SJ, Brandts CH. 2004. Oncolyitic viruses for the treatment of cancer: Current strategies and clinical trials. Drug Dis Today 9:759-768.
25. Wimmer E, Hellen CUT, Cao XM. 1993. Genetics of poliovirus. Annu Rev Genet 27:353-436.